EP3730132

COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISK

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    5.6.2013
  • :
    4.5.2022
  • :
    20165284.9
  • :
    4.6.2033
  • :
    COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISK

5.6.2013
4.5.2022
  • :
    Nalpropion Pharmaceuticals LLC
  • :
    155 Franklin Rd, Suite 450, Brentwood, TN 37027, US
  • :
    KLASSEN, Preston
  • :
    La Jolla, CA 92037, US
  • :
    TAYLOR, Kristin
  • :
    San Diego, CA 92127, US
  • :
    201261656451 P
  • :
    6.6.2012
  • :
    US
  • :
    A61K 31/137, A61K 31/485, A61P 3/04, A61P 9/00, A61P 9/04, A61P 9/10, A61K 9/20, G01G 19/414, G09B 5/06, G09B 19/00, G16H 20/10